Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glutamine transporters are membrane proteins that facilitate the movement of glutamine across cellular membranes. They belong to several solute carrier (SLC) gene families, including SLC1, SLC6, SLC7 and SLC38. These transporters play crucial roles in nutrient absorption, reabsorption, neurotransmitter cycling, and metabolic regulation. ASCT2/SLC1A5 is a major glutamine transporter, particularly in cancer cells, and its inhibition is explored as a therapeutic strategy. They utilize Na+-dependent symport or antiport mechanisms.
Inhibition of glutamine transport, impacting mTORC signaling
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glutamine Transporter.